Z-1288-2013 Class II Terminated

Recalled by Integra LifeSciences Corporation — Plainsboro, NJ

FDA device recall Z-1288-2013 was initiated by Integra LifeSciences Corporation on Mar 28, 2013 and is designated Class II. Reason for recall: Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products. The recall status is terminated (terminated Jun 3, 2015). Affected quantity: 17, 616 boxes.

Recall details

Product Type
Devices
Report Date
May 22, 2013
Initiation Date
Mar 28, 2013
Termination Date
Jun 3, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17, 616 boxes

Product description

INSTAT - Agent, Absorbable Hemostatic, Collagen Based INSTAT MCH is recommended for use in surgical procedures (other than Urological and Ophthalmological surgery) as an adjunct to hemostatis when control of bleeding by ligature or conventional procedures is ineffective or impractical.

Reason for recall

Due to the process deviation, product lots in question may have been released with higher levels of pyrogens than permitted by the specifications for the products.

Distribution pattern

Worldwide distribution: USA (nationwide) including Puerto Rico and countries of: Arab Emirates, Argentina, Belgium, Brasil, Canada, Chile, China, Costa Rica, Denmark, Egypt, Spain, France, Great Britain, Italy, Japan, Peru, Singapore, Thailand, and South Africa.

Code information

1105177, 1105178 1110143, 1110227 1110228, 1110229 1110230, 1110233 1110786, 1110787 1111356, 1105179 111023 1, 1110232 1110785

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1288-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1288-2013. Report a data issue: hello@regdatalab.com.